Objective: Mechanisms of dyspnea in obesity remain unclear. This study was undertaken to determine the relationships between dyspnea and pulmonary function including inspiratory muscle endurance (IME) in morbidly obese patients before bariatric surgery. Research methods and procedures: Fifty-five patients with a mean7s.d. body mass index (BMI) of 49.477.0 kg/m 2 were included. Dyspnea was evaluated by the Baseline Dyspnea Index (BDI; 0-12, 0 ¼ maximal dyspnea). Pulmonary function tests included a plethysmography, maximal inspiratory pressure (PImax) and IME was assessed by the incremental threshold loading test, determining the maximal pressure sustained for 2 min (Plim 2 ) and Plim 2 /PImax ratio. Patients were classified according to their BMI in two groups: BMI p49 (n ¼ 27) and 449 kg/m 2 (n ¼ 28 
Introduction
The prevalence of obesity is increasing rapidly, especially in industrialized countries. Morbid obesity, defined by a body mass index (BMI) above 40 kg/m 2 , is highly related to the risk of respiratory complications, 1 particularly obstructive sleep apnea syndrome 2 (OSAS) and obesity-hypoventilation syndrome 3 
(OHS).
Many studies have shown pulmonary function abnormalities in obese patients. [4] [5] [6] [7] [8] [9] [10] The most frequent pulmonary function tests (PFTs) findings are reduced expiratory reserve volume (ERV), functional residual capacity (FRC) and total lung capacity (TLC), [4] [5] [6] 9 which are generally related to alterations in chest wall mechanics induced by an increased abdominal load. 8 These alterations reduce total respiratory compliance. 7 The work of breathing is markedly increased in patients with severe obesity. 11 Maximum voluntary ventilation as well as maximal inspiratory pressure (PImax) can also be low, [6] [7] [8] [9] [10] reflecting a decreased inspiratory muscle performance.
Dyspnea is a very common and disabling symptom in morbid obesity, but the mechanisms of breathlessness in obese individuals remain unclear. However, dyspnea in daily life has recently been shown to be moderately related to lung function tests including PImax. 12 The primary aim of our study was to investigate the physiologic correlates of dyspnea in patients with morbid obesity referred for a bariatric surgery. Our hypothesis was that patients with greater obesity would report a higher degree of dyspnea. Moreover, we wanted to explore which physiologic variables would be related to the expected increased breathlessness in these patients. The secondary aim of the study was to evaluate the level of inspiratory muscle dysfunction (regarding both strength and endurance) in severely obese patients. We hypothesized that this dysfunction would be more pronounced in patients with a very severe obesity.
Materials and methods

Patients
We studied 55 patients (12 males, 43 females) aged 39.478.1 (mean7s.d.) years with a severe obesity. All these patients were referred to our laboratory for a systematic respiratory evaluation before a surgical treatment for a refractory morbid obesity. These patients were therefore not selected according to their dyspnea intensity. Indications for bariatric surgery in our institution were as follows: age X18 years; morbid obesity defined by a BMI 440 kg/m 2 or a BMI between 35 and 40 kg/m 2 associated with one or more of the following complications: diabetes mellitus, OSAS or dyslipidemia. Exclusion criteria were pregnancy, endocrinopathy-induced obesity, coexisting cardiac, pulmonary or neuromuscular disease. All patients were in stable condition at the time of assessment and none was already treated for OSAS. The study was approved by our ethics committee and all patients gave a written informed consent to participate. According to polysomnographic findings and daytime ABGs, patients were classified in three groups: obese without respiratory complication (OBESE) when both apnea-hypopnea index (AHI) was nonsignificant (o10/h) and daytime PaCO 2 in the normal range; OSAS when OSAS (defined by an AHI 410/h) was present with a normal daytime PaCO 2 ; and OHS when OHS was present, that is, when there was a daytime hypercapnia (PaCO 2 445 mm Hg) and hypoxemia unexplained by another cardiorespiratory disease, but with or without a coexisting OSAS.
Methods
Evaluation of inspiratory muscle strength. PImax was measured with a Validyne manometer connected to a mouthpiece with a small leak (1 mm of diameter) to prevent glottic closure.
The patient was seating and measurements were performed at FRC. PImax was determined as the PImax sustainable for 1 s. Five to seven trials were performed in each subject to obtain a coefficient of variation below 10%. The highest value was used in the analysis. Results of PImax were expressed in percentage (PImax% pred) of the predicted value according to Uldry and Fitting. 15 Inspiratory muscle weakness was defined by a significantly reduced PImax, considered below mean pred À1.64 s.d.
Inspiratory muscle endurance. Inspiratory muscle endurance (IME) was assessed by the incremental threshold loading (ITL) test as described previously, 16 except that a modified commercial Threshold IMT (Respironics) device with a spring-loaded valve was used instead of a weighted plunger. 17 
Results
Clinical characteristics
As presented in Table 1 , a majority of subjects were female and a small percentage was current or previous smokers (20% combined). Mean dyspnea was moderate but breathlessness was considered as severe (BDI score o6) in 20/55 (36%) with higher proportion in the BMI 449 kg/m 2 group (Po0.05).
BDI score was significantly higher (less dyspnea) in the BMI p49 kg/m 2 group compared to the BMI 449 kg/m 2 group (Po0.01). There was no significant differences for age, and number of OSAS and OHS, except a slightly higher proportion of OHS patients in the BMI 449 kg/m 2 group (P ¼ 0.07).
There was a larger proportion of current or previous smokers in the BMI p49 kg/m 2 group compared to the BMI 449 kg/m 2 group (Po0.05). Among OHS patients, 5/14 had a coexisting OSAS.
Lung function
Results of PFTs and blood gases are shown in Correlation between dyspnea and clinical or functional parameters As presented in Table 4 , the relationships between dyspnea and clinical or functional parameters remained low to moderate when considering the whole population of patients. The best correlations were found with VC% pred (Figure 1 ) and Plim 2 /PImax. Higher correlations were found in the BMI p49 kg/m 2 group (Table 4) 
Discussion
Our study showed that dyspnea in a population of morbid obese individuals was on average moderate in intensity but higher in patients with a very severe obesity (BMI 449 kg/ m 2 ). Dyspnea was moderately related to lung function and inspiratory muscle performance. However, this correlation was more significant in patients with a lower BMI, below 49 kg/m 2 . This category of obese patients had greater inspiratory muscle strength and endurance compared to those with a BMI 449 kg/m 2 . Although described in 1984, and widely used in other diseases such as COPD, 21 BDI score Physiologic correlates of dyspnea F Collet et al has never been used to our knowledge in the field of obesity research. At present, there is no specific tool to assess dyspnea in obesity. The only study which analyzed the relationship between dyspnea and PFTs was based on the Borg Scale Dyspnea Index. 12 This dyspnea index provides a good evaluation of dyspnea during exercise but has not been validated to quantify breathlessness in daily life. The BDI score appears to be a much better index, as it evaluates the severity of dyspnea-induced functional impairment in professional and home activity, together with magnitude of effort and magnitude of task.
As described previously, [4] [5] [6] 9 our study showed minor effects of obesity on lung volumes. Based on our selection criteria, airway function was not significantly abnormal in the whole population. The most consistent finding was a reduction in ERV and in FRC. These abnormalities are due to the effect of the abdominal content on diaphragm position. 8 A significant restriction was found in a minority of patients and was more frequent in patients with the highest BMI. However, the differences between the two groups did not reach statistical significance. Sahebjami and Gartside 10 showed in a population of 63 obese males a 25% reduction in TLC, especially in patients with a decrease in maximal minute ventilation. The differences between this study and our results could be explained by the large percentage of females in our population. The fat distribution in males is predominant in the trunk and in the upper body and could thus induce a higher increase in abdominal load. 22 This hypothesis remains controversial, as the lung abnormalities in a population of obese type 2 diabetic women were not related to truncal body fat composition. 23 A more precise quantification of abdominal and chest wall fat mass by methods such as magnetic resonance imaging could help to determine the relationship between lung restriction and body fat distribution. Lung restriction occurs rarely in obese patients and is mainly seen in individuals with OHS, 6, 24 as also shown in our OHS subset. PaCO 2 in the patients with a BMI 449 kg/m 2 was significantly higher compared to the BMI p49 kg/m 2 group. The slightly higher percentage of OHS in the BMI 449 kg/m 2 group could explain this difference, as OHS is more frequent in the most severely obese patients. 3 Inspiratory muscle strength was in the normal range in our whole population, but, as expected and previously described by Ray et al., 6 it was influenced by the severity of obesity.
PImax is a static maneuver and is not sufficient alone to correctly evaluate dynamic inspiratory muscle performance. As a consequence, inspiratory muscle function evaluation was completed by an IME assessment. IME seems to be much more relevant than PImax in pulmonary diseases as steroiddependent asthma, chronic obstructive pulmonary disease 25 or sarcoidosis. 18, 26 Inspiratory threshold loading (ITL) is the most commonly used to evaluate IME in humans 23 . It has been shown that maximal minute ventilation measurement is influenced by both inspiratory and expiratory flow rates. 27 Moreover, subjects' motivation and effort can affect the maneuver. 19 ITL is a more specific test to evaluate inspiratory muscle performance. Training does not significantly modify the results of ITL and breathing pattern does not need to be controlled to ensure a good reproducibility. 16 To our knowledge, only Weiner et al. 28 evaluated ITL in obese patients.
Determinants of decreased inspiratory muscle performance in obesity remain poorly defined. Inspiratory loading owing to chest wall and abdominal changes is likely to be an important component of inspiratory muscle dysfunction.
Our results showed that a majority of patients exhibited an impaired IME. Moreover, IME expressed in absolute value (Plim 2 ) was lower in patients with a BMI 449 kg/m 2 , but the difference between the two groups did not reach statistical significance. Although the proportion of OHS patients was marginally different between groups, the severity of obesity seems to influence mainly inspiratory muscle strength in our study. Our results are consistent with those of Weiner et al., 28 who demonstrated a marked decrease in IME, significantly improved after successful gastroplasty. Experimental studies in normal subjects showed that sleep loss might alter inspiratory muscle performance. 29 This mechanism could explain in part the impairment of IME. Consistent with this finding, IME was significantly lower in OSAS patients compared to OHS patients, OSAS patients exhibiting an AHI higher than OHS patients (37.2726.0 vs 28.6726.5). However, other recent studies did not find any evidence of diaphragmatic muscle fatigue during sleep apnea. 30, 31 The finding of a higher IME in OHS vs OSAS patients and the lack of relationship between PaCO2 and inspiratory muscle function suggests that a reduced IME is not a major determinant of daytime hypoventilation in OHS. Structural muscle changes could also contribute to inspiratory muscle dysfunction in obesity. There are no available data on diaphragm morphology and histochemistry in human obesity. In obese rats, a fast to slow shift in myosin heavy-chain isoforms of diaphragm and parasternal fibers has been described, 32 which would rather favor an enhanced resistance to fatigue of these muscles. This adaptive shift in MHC isoforms to inspiratory load is prevented by early leptin administration in young ob mice. 33 If a similar adaptation occurs in human obesity, it seems insufficient to maintain a normal IME. Finally, the oxygen cost of breathing at rest is increased in obese patients. 34 One hypothesis is that inspiratory muscle oxygen request during the ITL test could not be adequately satisfied, leading to diaphragmatic dysfunction. Dyspnea perception results from physiological as well as psychophysical sensory mechanisms. Signals arising from chemical, muscular, neurological and pulmonary receptors are as much determinants of dyspnea sensation. 35 We showed a relationship between dyspnea and BMI (Rho ¼ À0.26, P ¼ 0.04). Moreover, dyspnea was more severe in the BMI 449 kg/m 2 group compared to the BMI p49 kg/m 2 . The severity of obesity seems to be an important determinant of dyspnea in these patients. In 23 obese individuals free of coexisting pathology, Sahebjami 12 found
Physiologic correlates of dyspnea F Collet et al that dyspneic patients had higher BMI than non-dyspneic patients. In this study, the proportion of smokers was higher in the dyspneic group, and it seems therefore difficult to conclude that dyspnea could be attributable to obesity alone. Expiratory flow limitation has also been described in obesity, particularly in supine position and has been linked to an airway closure at low FRC. 36 The relationship between expiratory flow limitation and daytime dyspnea has not been evaluated in obesity. Left ventricular filling abnormalities have been described in morbid obese patients without symptoms of cardiac failure. 37 This diastolic dysfunction could be considered as a subclinical form of cardiomyopathy in obese individuals. These cardiac abnormalities might also contribute to the dyspnea sensation. Dyspnea was found to be related to inspiratory muscle performance, especially in the BMI p49 kg/m 2 group. Surprisingly, our study was unable to find any relationship between dyspnea and PFTs including inspiratory muscle performance in patients with a BMI 449 kg/m 2 . Our hypothesis is that the major load on the chest wall is the predominant determinant of dyspnea in these severely obese patients. Moreover, the imbalance between mechanical load and inspiratory muscle performance is difficult to assess in these patients. Other determinants as peripheral skeletal muscle dysfunctions 38 or deconditioning could also partly explain dyspnea sensation in this category of obese individuals. We found a relationship between dyspnea and three main parameters: BMI, FEV 1 % pred and Plim 2 /PImax (r ¼ 0.55, P ¼ 0.005). However, this combination is far to explain fully dyspnea perception in obese patients, suggesting that other factors could participate, such as psychological factors not evaluated in our study.
The main limit of our study is that inspiratory muscle performance was assessed by volitional methods, which could blunt the differences between groups. Validated nonvolitional and non-invasive methods to evaluate inspiratory muscle strength are clearly lacking in obesity. Cervical magnetic stimulation has not been evaluated in severe obesity, but there is some doubt about the supramaximality of phrenic nerve stimulation in this condition. Moreover, all methods evaluating IME are volitional.
Another limitation is that our patients were predominantly female and relatively young owing to the recruitment bias of bariatric surgery. Our population probably does not reflect the whole population of obese individuals. The level of inspiratory muscle dysfunction could significantly increase with age, abdominal fat distribution (particularly in males) and be influenced by frequent coexisting diseases in older obese patients such as diabetes mellitus and cardiac failure.
In conclusion, our results showed that dyspnea in morbidly obese patients remains moderately related to resting lung function and inspiratory muscle performance. This correlation is much more significant in patients with a BMI p49 kg/m 2 . Inspiratory muscle impairment could in part explain dyspnea sensation in these patients but other factors are likely to contribute to this symptom, reflecting the complexity of dyspnea mechanisms. Although inspiratory muscle dysfunction remained moderate in a majority of obese patients, IME assessment in addition to standard PFTs appears useful in those with severe dyspnea or when considering bariatric surgery.
